#KO
### ğŸ’Š ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - íš¨ëŠ¥ ë° íš¨ê³¼
* ì´ ì•½ì€ ê³„ì ˆì„± ë° ë‹¤ë…„ì„± ì•Œë ˆë¥´ê¸°ì„± ë¹„ì—¼, ì•Œë ˆë¥´ê¸°ì„± ê²°ë§‰ì—¼, ë§Œì„± íŠ¹ë°œì„± ë‘ë“œëŸ¬ê¸°, í”¼ë¶€ê°€ë ¤ì›€ì¦ê³¼Â í•˜ì´ë“œë¡œì½”í‹°ì† ì™¸ìš©ì œì™€ ë³‘ìš©ì— ì˜í•œ ìŠµì§„, í”¼ë¶€ì—¼ì— ì‚¬ìš©í•©ë‹ˆë‹¤.

### ğŸ•’ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ìš©ë²• ë° ìš©ëŸ‰
* ì„±ì¸ ë° 6ì„¸ ì´ìƒì˜ ì†Œì•„ëŠ” 1ì¼ 1íšŒ 1ì •(10 mg)ì„ ì·¨ì¹¨ ì „ì— ë³µìš©í•˜ê³ , ì´ìƒë°˜ì‘ì— ë¯¼ê°í•œ í™˜ìì˜ ê²½ìš°ëŠ”Â 1/2ì •(5 mg)ì”©ì„ ì•„ì¹¨, ì €ë…ì— ë¶„í•  ë³µìš©í•©ë‹ˆë‹¤.

ì—°ë ¹, ì¦ìƒì— ë”°ë¼ ì ì ˆíˆ ì¦ê°í•©ë‹ˆë‹¤.

ì‹ ì¥ì•  í™˜ìì˜ íˆ¬ì—¬ ê°„ê²©ì€ í™˜ìì˜ ì‹ ê¸°ëŠ¥ì— ë”°ë¼ ì¡°ì ˆë˜ì–´ì•¼ í•˜ê³ , ì‹ ì¥ì• ë¥¼ ê°€ì§„ ì†Œì•„ í™˜ìëŠ” í™˜ìì˜ ì‹  ì²­ì†Œìœ¨ê³¼ ì²´ì¤‘ì„ ê³ ë ¤í•˜ì—¬ ê°œë³„ì ìœ¼ë¡œ ìš©ëŸ‰ì„ ì¡°ì ˆí•´ì•¼ í•˜ë¯€ë¡œ ìì„¸í•œ ì‚¬í•­ì€ í—ˆê°€ì‚¬í•­ì„ ì°¸ê³ í•˜ì‹­ì‹œì˜¤.

### âš ï¸ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ì£¼ì˜ì‚¬í•­
* ì •ë³´ ì—†ìŒ
* ì´ ì•½ ë° íˆë“œë¡ì‹œì§„ ë˜ëŠ” í”¼í˜ë¼ì§„ ìœ ë„ì²´ì— ê³¼ë¯¼ì¦ í™˜ì, ì‹ ë¶€ì „ í™˜ì(í¬ë ˆì•„í‹°ë‹Œ ì²­ì†Œìœ¨ 

ì´ ì•½ì„ ë³µìš©í•˜ê¸° ì „ì— ì„ë¶€, ìˆ˜ìœ ë¶€, ì‹ ì¥ì• , ê°„ì¥ì•  í™˜ì, ë…¸ì¸, ë‡Œì „ì¦ í™˜ì ë° ë°œì‘ ìœ„í—˜ì„±ì´ ìˆëŠ” í™˜ì, ì†Œë³€ê³ ì„ì˜ ì„ í–‰ìš”ì¸(ì²™ìˆ˜ ë³‘ë³€, ì „ë¦½ì„  ë¹„ëŒ€ì¦)ì´ ìˆëŠ” í™˜ìëŠ” ì˜ì‚¬ ë˜ëŠ” ì•½ì‚¬ì™€ ìƒì˜í•˜ì‹­ì‹œì˜¤.

# EN
### ğŸ’Š ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Efficacy and Effects
*   This medicine is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, skin pruritus, and eczema and dermatitis when used concomitantly with topical hydrocortisone.

### ğŸ•’ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Dosage and Administration
*   Adults and children aged 6 years and older should take 1 tablet (10 mg) once daily before bedtime. For patients sensitive to adverse reactions, take 1/2 tablet (5 mg) in divided doses in the morning and evening.

    Dosage may be appropriately increased or decreased depending on age and symptoms.

    The dosing interval for patients with renal impairment should be adjusted according to the patient's renal function. For pediatric patients with renal impairment, the dosage should be individually adjusted considering the patient's renal clearance and body weight. Please refer to the prescribing information for detailed instructions.

### âš ï¸ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Precautions
*   No information provided.
*   This medicine is contraindicated in patients with hypersensitivity to this drug, hydroxyzine, or piperazine derivatives, and in patients with renal failure (creatinine clearance <10 mL/min).

    Before taking this medicine, pregnant women, breastfeeding women, patients with renal impairment, hepatic impairment, the elderly, patients with epilepsy or those at risk of seizures, and patients with predisposing factors for urinary retention (e.g., spinal cord lesion, prostatic hypertrophy) should consult a doctor or pharmacist.

---

# CN
### ğŸ’Š ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - åŠŸæ•ˆä¸ä½œç”¨
*   æœ¬è¯ç”¨äºæ²»ç–—å­£èŠ‚æ€§åŠå¸¸å¹´æ€§è¿‡æ•æ€§é¼»ç‚ã€è¿‡æ•æ€§ç»“è†œç‚ã€æ…¢æ€§ç‰¹å‘æ€§è¨éº»ç–¹ã€çš®è‚¤ç˜™ç—’ç—‡ï¼Œä»¥åŠä¸æ°¢åŒ–å¯çš„æ¾å¤–ç”¨åˆ¶å‰‚è”åˆç”¨è¯æ²»ç–—æ¹¿ç–¹å’Œçš®ç‚ã€‚

### ğŸ•’ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ç”¨æ³•ç”¨é‡
*   æˆäººåŠ6å²ä»¥ä¸Šå„¿ç«¥æ¯æ—¥ä¸€æ¬¡ï¼Œæ¯æ¬¡1ç‰‡ï¼ˆ10 mgï¼‰ï¼Œç¡å‰æœç”¨ã€‚å¯¹ä¸è‰¯ååº”æ•æ„Ÿçš„æ‚£è€…ï¼Œå¯å°†1/2ç‰‡ï¼ˆ5 mgï¼‰åˆ†æ—©æ™šä¸¤æ¬¡æœç”¨ã€‚

    å‰‚é‡å¯æ ¹æ®å¹´é¾„å’Œç—‡çŠ¶é€‚å½“å¢å‡ã€‚

    è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…çš„ç»™è¯é—´éš”åº”æ ¹æ®æ‚£è€…çš„è‚¾åŠŸèƒ½è¿›è¡Œè°ƒæ•´ï¼›æ‚£æœ‰è‚¾åŠŸèƒ½ä¸å…¨çš„å„¿ç«¥æ‚£è€…ï¼Œåº”ç»¼åˆè€ƒè™‘æ‚£è€…çš„è‚¾æ¸…é™¤ç‡å’Œä½“é‡æ¥ä¸ªä½“åŒ–è°ƒæ•´å‰‚é‡ï¼Œè¯¦æƒ…è¯·å‚è€ƒè¯å“è¯´æ˜ä¹¦ã€‚

### âš ï¸ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - æ³¨æ„äº‹é¡¹
*   æ— ä¿¡æ¯ã€‚
*   å¯¹æœ¬è¯ã€ç¾Ÿå—ªæˆ–å“Œå—ªè¡ç”Ÿç‰©è¿‡æ•çš„æ‚£è€…ï¼Œä»¥åŠè‚¾åŠŸèƒ½è¡°ç«­æ‚£è€…ï¼ˆè‚Œé…æ¸…é™¤ç‡ <10 mL/minï¼‰ç¦ç”¨æœ¬è¯ã€‚

    æœç”¨æœ¬è¯å‰ï¼Œå­•å¦‡ã€å“ºä¹³æœŸå¦‡å¥³ã€è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…ã€è‚åŠŸèƒ½ä¸å…¨æ‚£è€…ã€è€å¹´äººã€ç™«ç—«æ‚£è€…åŠæœ‰ç™«ç—«å‘ä½œé£é™©çš„æ‚£è€…ã€ä»¥åŠæœ‰å°¿æ½´ç•™å…ˆå†³æ¡ä»¶ï¼ˆå¦‚è„Šé«“ç—…å˜ã€å‰åˆ—è…ºè‚¥å¤§ï¼‰çš„æ‚£è€…ï¼Œåº”å’¨è¯¢åŒ»ç”Ÿæˆ–è¯å¸ˆã€‚

---

# JP
### ğŸ’Š ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - åŠ¹èƒ½ãƒ»åŠ¹æœ
*   æœ¬å‰¤ã¯ã€å­£ç¯€æ€§ãŠã‚ˆã³é€šå¹´æ€§ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§é¼»ç‚ã€ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§çµè†œç‚ã€æ…¢æ€§ç‰¹ç™ºæ€§è•éº»ç–¹ã€çš®è†šãã†ç—’ç—‡ã€ãªã‚‰ã³ã«ãƒ’ãƒ‰ãƒ­ã‚³ãƒ«ãƒã‚¾ãƒ³å¤–ç”¨å‰¤ã¨ã®ä½µç”¨ã«ã‚ˆã‚‹æ¹¿ç–¹ã€çš®è†šç‚ã«ç”¨ã„ã‚‰ã‚Œã¾ã™ã€‚

### ğŸ•’ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ç”¨æ³•ãƒ»ç”¨é‡
*   æˆäººãŠã‚ˆã³6æ­³ä»¥ä¸Šã®å°å…ã¯ã€1æ—¥1å›1éŒ ï¼ˆ10 mgï¼‰ã‚’å°±å¯å‰ã«æœç”¨ã—ã€å‰¯ä½œç”¨ã«æ•æ„Ÿãªæ‚£è€…ã®å ´åˆã¯ã€1/2éŒ ï¼ˆ5 mgï¼‰ã‚’æœã€å¤•ã«åˆ†å‰²ã—ã¦æœç”¨ã—ã¾ã™ã€‚

    å¹´é½¢ã€ç—‡çŠ¶ã«å¿œã˜ã¦é©å®œå¢—æ¸›ã—ã¾ã™ã€‚

    è…æ©Ÿèƒ½éšœå®³æ‚£è€…ã®æŠ•ä¸é–“éš”ã¯ã€æ‚£è€…ã®è…æ©Ÿèƒ½ã«å¿œã˜ã¦èª¿ç¯€ã•ã‚Œã‚‹ã¹ãã§ã‚ã‚Šã€è…æ©Ÿèƒ½éšœå®³ã‚’æœ‰ã™ã‚‹å°å…æ‚£è€…ã¯ã€æ‚£è€…ã®è…ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ã¨ä½“é‡ã‚’è€ƒæ…®ã—ã¦å€‹åˆ¥ã«ç”¨é‡ã‚’èª¿ç¯€ã™ã‚‹å¿…è¦ãŒã‚ã‚‹ãŸã‚ã€è©³ç´°ã«ã¤ã„ã¦ã¯æ·»ä»˜æ–‡æ›¸ã‚’å‚ç…§ã—ã¦ãã ã•ã„ã€‚

### âš ï¸ ì•Œë ˆë¦¬ì§„ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - æ³¨æ„äº‹é …
*   æƒ…å ±ãªã—
*   æœ¬å‰¤ãŠã‚ˆã³ãƒ’ãƒ‰ãƒ­ã‚­ã‚·ã‚¸ãƒ³ã¾ãŸã¯ãƒ”ãƒšãƒ©ã‚¸ãƒ³èª˜å°ä½“ã«éæ•ç—‡ã®æ‚£è€…ã€è…ä¸å…¨æ‚£è€…ï¼ˆã‚¯ãƒ¬ã‚¢ãƒãƒ‹ãƒ³ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ <10 mL/minï¼‰ã«ã¯ç¦å¿Œã€‚

    æœ¬å‰¤ã‚’æœç”¨ã™ã‚‹å‰ã«ã€å¦Šå©¦ã€æˆä¹³å©¦ã€è…æ©Ÿèƒ½éšœå®³æ‚£è€…ã€è‚æ©Ÿèƒ½éšœå®³æ‚£è€…ã€é«˜é½¢è€…ã€ã¦ã‚“ã‹ã‚“æ‚£è€…ãŠã‚ˆã³ç™ºä½œã®ãƒªã‚¹ã‚¯ãŒã‚ã‚‹æ‚£è€…ã€å°¿é–‰ã®ç´ å› ï¼ˆè„Šé«„ç—…å¤‰ã€å‰ç«‹è…ºè‚¥å¤§ç—‡ãªã©ï¼‰ãŒã‚ã‚‹æ‚£è€…ã¯ã€åŒ»å¸«ã¾ãŸã¯è–¬å‰¤å¸«ã«ã”ç›¸è«‡ãã ã•ã„ã€‚